Yahoo this week unveiled Scout, an AI-powered "answer engine" now in beta across desktop (at scout.yahoo.com), mobile ...

Since ChatGPT made its debut in late 2022, literally dozens of frameworks for building AI agents have emerged. Of them, ...

Several months back, the LEGO Ideas people asked fans to submit designs for sets celebrating the 1990s. The winner of the “Build Your Nostalgia” challenge has just been announced: it’s a big, ...

Once data is loaded into Excel, Copilot allows users to ask questions in natural language instead of building new formulas.

Discover the leading database management systems for enterprises in 2026. Explore key features, pricing, and implementation tips for selecting the best DBMS software to harness your data effectively.

Our columnist explores the new 'AI continuum' from a developer's perspective, dispels some misconceptions, addresses the skills gap, and offers some practical strategies for marshaling the power of ...

Discover the best business intelligence (BI) tools of 2026 that help enterprises transform data into actionable insights.

Overview On January 14, NSFOCUS CERT detected that Microsoft released the January Security Update patch, which fixed 112 security issues involving widely used products such as Windows, Microsoft ...

Critical105Important0Moderate0LowMicrosoft addresses 113 CVEs in the first Patch Tuesday of 2026, with two zero-days, including one that was exploited in the wild.Microsoft patched 113 CVEs in its ...

Washington — After two previous unsuccessful attempts, the Senate moved Thursday toward limiting President Trump's ability to further strike Venezuela as the U.S. leader continues to take unilateral ...

WASHINGTON (AP) — The Trump administration has launched what officials describe as the largest federal immigration enforcement operation ever carried out, preparing to deploy as many as 2,000 federal ...

Boston-based Aktis Oncology has filed to go public in the U.S., according to multiple news reports. The company has operations in Durham. A radiopharmaceutical drug developer, Aktis made SEC filings ...